FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Brain MRI Surveillance Alone May Be Enough in SCLC

2.

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

3.

iPSC-based vaccines: A new hope for preventing and treating colorectal cancer

4.

All-Oral Treatment Combo for AML Earns FDA Nod

5.

Trial Questions Role of Dual Immunotherapy in First-Line NSCLC


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot